Multimodality Imaging for Assessment of Myocardial Viability: Nuclear, Echocardiography, MR, and CT
暂无分享,去创建一个
[1] Jeroen J. Bax,et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. , 1998, Journal of the American College of Cardiology.
[2] C. O'connor,et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. , 2011, The New England journal of medicine.
[3] R. Bonow,et al. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. , 1999, Journal of the American College of Cardiology.
[4] M. Schwaiger,et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. , 1994, Circulation.
[5] V. Dilsizian. 18F-FDG Uptake as a Surrogate Marker for Antecedent Ischemia , 2008, Journal of Nuclear Medicine.
[6] H. Schelbert,et al. Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. , 1994, Journal of the American College of Cardiology.
[7] D. Berman,et al. Myocardial viability and survival in ischemic left ventricular dysfunction. , 2011, The New England journal of medicine.
[8] J. Oh,et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. , 1998, Journal of the American College of Cardiology.
[9] M. Phelps,et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. , 1995, Circulation.
[10] M Schwaiger,et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. , 1997, Journal of the American College of Cardiology.
[11] C. Indolfi,et al. Low dose dobutamine echocardiography for predicting functional recovery after coronary revascularisation , 2001, Heart.
[12] V. Dilsizian,et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. , 1990, The New England journal of medicine.
[13] S. Bergmann,et al. Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction. , 2001, The American journal of cardiology.
[14] S. Kaul,et al. Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[15] R. Kim,et al. Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function , 2001, Circulation.
[16] H. Schelbert,et al. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[17] J. Mattera,et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. , 1999, Circulation.
[18] V. Dilsizian,et al. Imaging myocardial metabolism and ischemic memory , 2008, Nature Clinical Practice Cardiovascular Medicine.
[19] V. Dilsizian,et al. Metabolic Imaging With &bgr;-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia , 2005, Circulation.
[20] L. Shaw,et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.
[21] V. Dilsizian,et al. PET myocardial perfusion and metabolism clinical imaging , 2009 .
[22] W. Zoghbi,et al. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. , 1995, Circulation.
[23] M. Verani,et al. Identification of Hibernating Myocardium With Quantitative Intravenous Myocardial Contrast Echocardiography: Comparison With Dobutamine Echocardiography and Thallium-201 Scintigraphy , 2003, Circulation.
[24] J. Griffith,et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. , 1994, Circulation.
[25] F. Bénard,et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. , 2009, JACC. Cardiovascular imaging.
[26] A. Soricelli,et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography. , 1996, Circulation.
[27] Jeroen J. Bax,et al. Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function. , 2001, The American journal of cardiology.
[28] Jeroen J. Bax,et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. , 2001, Journal of the American College of Cardiology.
[29] A. Weyman,et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. , 1995, Circulation.
[30] V. Dilsizian,et al. Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction. , 1998, The American journal of cardiology.
[31] V. Dilsizian,et al. [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? , 1998, Circulation.
[32] M. Schwaiger,et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. , 1992, Journal of the American College of Cardiology.
[33] Allen J. Taylor,et al. Viability imaging by cardiac computed tomography. , 2010, Journal of cardiovascular computed tomography.
[34] T. Marwick,et al. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. , 1992, The American journal of cardiology.
[35] Raymond Y Kwong,et al. Diagnostic and Prognostic Value of Cardiac Magnetic Resonance Imaging in Assessing Myocardial Viability , 2008, Topics in magnetic resonance imaging : TMRI.
[36] R. Sciagrà,et al. Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated spect versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[37] Stefan Neubauer,et al. Value of Delayed-Enhancement Cardiovascular Magnetic Resonance Imaging in Predicting Myocardial Viability After Surgical Revascularization , 2004, Circulation.
[38] Jeroen J. Bax,et al. Prognostic role of dobutamine stress echocardiography in myocardial viability , 2006, Current opinion in cardiology.
[39] G. Rodriguez-Granillo,et al. Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention. , 2009, JACC. Cardiovascular imaging.
[40] G. Gioia,et al. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction , 1996, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[41] Eckart Fleck,et al. Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar Quantification for the Prediction of Functional Recovery , 2004, Circulation.
[42] S L Bacharach,et al. 13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. , 1999, Journal of the American College of Cardiology.
[43] S. Kaul,et al. Quantitative Planar Rest‐Redistribution 201 Imaging in Detection of Myocardial Viability and Prediction of Improvement in Left Ventricular Function After Coronary Bypass Surgery in Patients With Severely Depressed Left Ventricular Function , 1993, Circulation.
[44] N. Mullani,et al. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[45] V. Dilsizian. Myocardial viability: contractile reserve or cell membrane integrity? , 1996, Journal of the American College of Cardiology.
[46] M. Penicka,et al. Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization. , 2007, European Heart Journal.
[47] Jeroen J. Bax,et al. Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction. , 2001, The American journal of cardiology.
[48] P. Franken,et al. BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction , 1999, The International Journal of Cardiac Imaging.
[49] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[50] R O Bonow,et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. , 1998, Circulation.
[51] Edwin Wu,et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.
[52] S L Bacharach,et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. , 1991, Circulation.
[53] André Lamy,et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). , 2007, Journal of the American College of Cardiology.
[54] H. Schelbert,et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. , 1998, Journal of the American College of Cardiology.
[55] M Schwaiger,et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.
[56] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[57] G. Beller,et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. , 1997, Circulation.
[58] V. Dilsizian. Cardiac magnetic resonance versus spect: are all noninfarct myocardial regions created equal? , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[59] V. Dilsizian,et al. Assessment of myocardial viability by radionuclide and echocardiographic techniques: is it simply a sensitivity and specificity issue? , 2006, Current opinion in cardiology.